ABBV vs. ATR: A Head-to-Head Stock Comparison

Updated on October 14, 2025

Here’s a clear look at ABBV and ATR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	ABBV	ATR
Company Name	AbbVie Inc.	AptarGroup, Inc.
Country	United States	United States
GICS Sector	Health Care	Materials
GICS Industry	Biotechnology	Containers & Packaging
Market Capitalization	408.50 billion USD	8.67 billion USD
Exchange	NYSE	NYSE
Listing Date	January 2, 2013	April 23, 1993
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of ABBV and ATR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ABBV vs. ATR: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	ABBV	ATR
5-Day Price Return	-2.25%	-1.18%
13-Week Price Return	21.31%	-17.60%
26-Week Price Return	14.68%	-11.48%
52-Week Price Return	19.44%	-17.06%
Month-to-Date Return	-0.13%	-1.53%
Year-to-Date Return	30.13%	-16.23%
10-Day Avg. Volume	7.42M	0.39M
3-Month Avg. Volume	5.67M	0.43M
3-Month Volatility	23.99%	24.82%
Beta	0.36	0.53

Profitability

Return on Equity (TTM)

ABBV

95.59%

Biotechnology Industry

Max: 97.92%
Q3: 11.99%
Median: -19.30%
Q1: -51.29%
Min: -132.03%

In the upper quartile for the Biotechnology industry, ABBV’s Return on Equity of 95.59% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

ATR

15.30%

Containers & Packaging Industry

Max: 36.99%
Q3: 19.86%
Median: 10.47%
Q1: 6.76%
Min: -0.20%

ATR’s Return on Equity of 15.30% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.

ABBV vs. ATR: A comparison of their Return on Equity (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Net Profit Margin (TTM)

ABBV

6.45%

Biotechnology Industry

Max: 73.34%
Q3: 18.98%
Median: -12.96%
Q1: -105.72%
Min: -259.82%

ABBV’s Net Profit Margin of 6.45% is aligned with the median group of its peers in the Biotechnology industry. This indicates its ability to convert revenue into profit is typical for the sector.

ATR

10.86%

Containers & Packaging Industry

Max: 10.84%
Q3: 8.25%
Median: 4.91%
Q1: 3.65%
Min: -0.12%

ATR’s Net Profit Margin of 10.86% is exceptionally high, placing it well beyond the typical range for the Containers & Packaging industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

ABBV vs. ATR: A comparison of their Net Profit Margin (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Operating Profit Margin (TTM)

ABBV

18.80%

Biotechnology Industry

Max: 78.85%
Q3: 21.90%
Median: -13.30%
Q1: -109.94%
Min: -278.10%

ABBV’s Operating Profit Margin of 18.80% is around the midpoint for the Biotechnology industry, indicating that its efficiency in managing core business operations is typical for the sector.

ATR

14.26%

Containers & Packaging Industry

Max: 22.03%
Q3: 13.09%
Median: 8.06%
Q1: 6.46%
Min: -0.07%

An Operating Profit Margin of 14.26% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ABBV vs. ATR: A comparison of their Operating Profit Margin (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Profitability at a Glance

Symbol	ABBV	ATR
Return on Equity (TTM)	95.59%	15.30%
Return on Assets (TTM)	2.73%	8.50%
Net Profit Margin (TTM)	6.45%	10.86%
Operating Profit Margin (TTM)	18.80%	14.26%
Gross Profit Margin (TTM)	70.93%	38.32%

Financial Strength

Current Ratio (MRQ)

ABBV

0.74

Biotechnology Industry

Max: 16.97
Q3: 8.39
Median: 4.11
Q1: 2.64
Min: 0.74

ABBV’s Current Ratio of 0.74 falls into the lower quartile for the Biotechnology industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

ATR

1.21

Containers & Packaging Industry

Max: 1.96
Q3: 1.45
Median: 1.33
Q1: 1.09
Min: 0.87

ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.

ABBV vs. ATR: A comparison of their Current Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ABBV

49.22

Biotechnology Industry

Max: 1.92
Q3: 0.79
Median: 0.12
Q1: 0.00
Min: 0.00

With a Debt-to-Equity Ratio of 49.22, ABBV operates with exceptionally high leverage compared to the Biotechnology industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

ATR

0.40

Containers & Packaging Industry

Max: 4.15
Q3: 2.03
Median: 1.20
Q1: 0.53
Min: 0.23

Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

ABBV vs. ATR: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Interest Coverage Ratio (TTM)

ABBV

2.70

Biotechnology Industry

Max: 72.37
Q3: 1.03
Median: -9.59
Q1: -65.05
Min: -163.11

ABBV’s Interest Coverage Ratio of 2.70 is in the upper quartile for the Biotechnology industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

ATR

16.67

Containers & Packaging Industry

Max: 13.16
Q3: 8.10
Median: 3.38
Q1: 2.83
Min: 1.06

With an Interest Coverage Ratio of 16.67, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.

ABBV vs. ATR: A comparison of their Interest Coverage Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Financial Strength at a Glance

Symbol	ABBV	ATR
Current Ratio (MRQ)	0.74	1.21
Quick Ratio (MRQ)	0.48	0.83
Debt-to-Equity Ratio (MRQ)	49.22	0.40
Interest Coverage Ratio (TTM)	2.70	16.67

Growth

Revenue Growth

ABBV vs. ATR: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ABBV vs. ATR: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ABBV

2.76%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

ABBV’s Dividend Yield of 2.76% is exceptionally high, placing it well above the typical range for the Biotechnology industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.

ATR

1.38%

Containers & Packaging Industry

Max: 7.14%
Q3: 4.65%
Median: 3.69%
Q1: 2.00%
Min: 0.00%

ATR’s Dividend Yield of 1.38% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

ABBV vs. ATR: A comparison of their Dividend Yield (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Dividend Payout Ratio (TTM)

ABBV

226.84%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

At 226.84%, ABBV’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Biotechnology industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.

ATR

30.61%

Containers & Packaging Industry

Max: 222.75%
Q3: 132.16%
Median: 65.79%
Q1: 28.53%
Min: 0.00%

ATR’s Dividend Payout Ratio of 30.61% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ABBV vs. ATR: A comparison of their Dividend Payout Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Dividend at a Glance

Symbol	ABBV	ATR
Dividend Yield (TTM)	2.76%	1.38%
Dividend Payout Ratio (TTM)	226.84%	30.61%

Valuation

Price-to-Earnings Ratio (TTM)

ABBV

109.30

Biotechnology Industry

Max: 40.44
Q3: 39.37
Median: 22.12
Q1: 15.76
Min: 3.48

At 109.30, ABBV’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Biotechnology industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

ATR

22.12

Containers & Packaging Industry

Max: 24.22
Q3: 20.28
Median: 17.07
Q1: 15.06
Min: 7.79

A P/E Ratio of 22.12 places ATR in the upper quartile for the Containers & Packaging industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

ABBV vs. ATR: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Price-to-Sales Ratio (TTM)

ABBV

7.05

Biotechnology Industry

Max: 92.67
Q3: 41.36
Median: 8.45
Q1: 4.46
Min: 0.97

ABBV’s P/S Ratio of 7.05 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

ATR

2.40

Containers & Packaging Industry

Max: 1.99
Q3: 1.17
Median: 0.94
Q1: 0.55
Min: 0.31

With a P/S Ratio of 2.40, ATR trades at a valuation that eclipses even the highest in the Containers & Packaging industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ABBV vs. ATR: A comparison of their Price-to-Sales Ratio (TTM) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Price-to-Book Ratio (MRQ)

ABBV

261.01

Biotechnology Industry

Max: 22.72
Q3: 10.68
Median: 4.55
Q1: 2.44
Min: 0.59

At 261.01, ABBV’s P/B Ratio is at an extreme premium to the Biotechnology industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

ATR

3.83

Containers & Packaging Industry

Max: 4.79
Q3: 3.32
Median: 2.14
Q1: 1.60
Min: 0.89

ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

ABBV vs. ATR: A comparison of their Price-to-Book Ratio (MRQ) against their respective Biotechnology and Containers & Packaging industry benchmarks.

Valuation at a Glance

Symbol	ABBV	ATR
Price-to-Earnings Ratio (TTM)	109.30	22.12
Price-to-Sales Ratio (TTM)	7.05	2.40
Price-to-Book Ratio (MRQ)	261.01	3.83
Price-to-Free Cash Flow Ratio (TTM)	22.55	25.35